Although the medical relevance of the aforementioned cardiovascular chance factor alterations by tirzepatide will probably be assessed during the planned cardiovascular end result study SURPASS-CVOT ( "form":"clinical-demo","attrs": "textual content":"NCT04255433","term_id":"NCT04255433" NCT04255433), a pre-specified cardiovascular meta-Examination indicated that tirzepatide did not i... https://researchchemicals21975.blog2learn.com/76232168/toronto-research-chemicals-an-overview